Preparation and properties of nanoscale containers for biomedical application in drug delivery: Preliminary studies with kynurenic acid

Journal of Neural Transmission

Volumn 119, Issue 2, 2012, Pages 115-121

  Hornok, V ^a   Bujdoso T ^a   Toldi, J ^b   Nagy, K ^b   Demeter, I ^b   Fazakas, C ^c   Krizbai, I ^c   Vecsei L ^a   Dekany I ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Blood brain barrier; Encapsulation; Kynurenic acid; Micelles; Nanocontainers; Non ionic surfactants

Indexed keywords

KYNURENIC ACID; LUTENSOL AP 20; SURFACTANT; TRITON X 100; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEM; ELECTROPHYSIOLOGY; IN VIVO STUDY; MICELLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOMEDICAL TECHNOLOGY; COCULTURE TECHNIQUES; DRUG DELIVERY SYSTEMS; KYNURENIC ACID; MICELLES; NANOPARTICLES; RATS; RATS, WISTAR;

EID: 84857637250     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0726-2     Document Type: Article

References (28)

1. VK Aswal S De PS Goyal S Bhattacharya RK Heenan 1999 Micellar structures of dimeric surfactants with phosphate head groups and wettable spacers: a small-angle neutron scattering study Phys Rev E 59 3116 3122 10.1103/PhysRevE.59.3116 1:CAS:528:DyaK1MXhvV2mtL0%3D (Pubitemid 129306010)
2. KA Dill DE Koppel RS Cantor JD Dill D Bendedouch SH Chen 1984 Molecular conformations in surfactant micelles Nature 309 42 45 10.1038/309042a0 1:CAS:528:DyaL2cXitFKjs7o%3D (Pubitemid 14134133)
3. Evans DF, Wennerström H (1994) The colloidal domain-where physics, chemistry, biology and technology meet. VCH Publishers, USA
4. S Fukui R Schwarz SI Rapaport Y Takada QR Smith 1991 Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism J Neurochem 56 2007 2017 1827495 10.1111/j.1471-4159.1991.tb03460.x 1:CAS:528:DyaK3MXktVGltLY%3D
5. G Gregoriadis 1995 Engineering liposomes for drug delivery: progress and problems Trends Biotechnol 13 527 537 8595139 10.1016/S0167-7799(00)89017-4 1:CAS:528:DyaK2MXpslansbk%3D
6. G Gregoriadis AT Florence 1993 Liposomes in drug delivery: clinical, diagnostic and ophthalmic potential Drugs 45 15 28 7680982 10.2165/00003495- 199345010-00003 1:CAS:528:DyaK3sXktFGitbk%3D (Pubitemid 23093890)
7. P Hutamekain AE Farkas A Orbok I Wilhelm P Nagyoszi S Veszelka, et al. 2008 Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells Cell Biol Int 32 198 209 10.1016/j.cellbi.2007.08.026 (Pubitemid 351291674)
8. DL Iden TM Allen 2001 In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach Biochim Biophys Acta 1513 207 216 11470092 10.1016/S0005-2736(01) 00357-1 1:CAS:528:DC%2BD3MXltFyqurY%3D (Pubitemid 32706418)
9. JV Joshi VK Aswal PS Goyal 2007 Combined SANS and SAXS studies on alkali metal dodecyl sulphate micelles J Phys Condens Matter 19 196219 10.1088/0953-8984/19/19/196219 (Pubitemid 46774764)
10. T Kakudo S Chaki S Futaki I Nakase K Akaji T Kawakami K Maruyama H Kamiya H Harashima 2004 Transferrinmodified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system Biochemistry 43 5618 5628 15134436 10.1021/bi035802w 1:CAS:528:DC%2BD2cXjtlCgu7s%3D (Pubitemid 38623596)
11. ZST Kincses J Toldi L Vécsei 2010 Kynurenines, neurodegeneration and Alzheimer's disease J Cell Mol Med 14 2045 2054 20629991 10.1111/j.1582-4934.2010.01123.x 1:CAS:528:DC%2BC3cXhsVahurbL
12. Lindman B, Wennerström H (1980) Topics in current chemistry. Springer, Berlin, p 87
13. E Mastrobattista DJ Crommelin J Wilschut G Storm 2002 Targeted liposomes for delivery of protein-based drugs into the cytoplasm of tumor cells J Liposome Res 12 57 65 12604039 10.1081/LPR-120004777 1:CAS:528:DC%2BD38XmvVWltbw%3D (Pubitemid 34846957)
14. N Mori S Ohta 1992 Comparison of anticonvulsant effects of valproic acid entrapped in positively and negatively charged liposomes in amygdaloid-kindled rats Brain Res 593 329 331 1450941 10.1016/0006-8993(92)91330-H 1:CAS:528:DyaK38XmsFyju7s%3D
15. N Mori A Kurokouchi K Osonoe H Saitoh K Ariga K Suzuki Y Iwata 1995 Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats Brain Res 703 184 190 8719631 10.1016/0006-8993(95)01095-5 1:CAS:528:DyaK2MXpvVyrsLc%3D
16. H Németh H Robotka Z Kis É Rózsa T Janáky C Somlai M Marosi T Farkas J Toldi L Vécsei 2004 Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. Anelectrophysiological and behavioural study Neuropharmacology 47 916 925 15527825 10.1016/j.neuropharm.2004.06.007 (Pubitemid 39440985)
17. MJ Ostro PR Cullis 1989 Use of liposomes as injectable-drug delivery systems Am J Hosp Pharm 46 1576 1587 2672806 1:CAS:528:DyaL1MXls1Sjsb0%3D (Pubitemid 19201630)
18. WM Pardridge 1998 CNS drug design based on principles of blood-brain barrier transport J Neurochem 70 1781 1792 9572261 10.1046/j.1471-4159.1998. 70051781.x 1:CAS:528:DyaK1cXislSgtbk%3D (Pubitemid 28207799)
19. WM Pardridge 2002 Drug and gene delivery to the brain: the vascular route Neuron 36 555 558 12441045 10.1016/S0896-6273(02)01054-1 1:CAS:528: DC%2BD38Xpt1Kgsr0%3D (Pubitemid 35346750)
20. H Robotka H Németh C Somlai L Vécsei J Toldi 2005 Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus Eur J Pharamcol 513 75 80 10.1016/j.ejphar.2005.02.043 1:CAS:528:DC%2BD2MXjvVOhtr4%3D (Pubitemid 40692248)
21. K Sas Á Párdutz J Toldi L Vécsei 2010 Dementia, stroke and migraine-some common pathological mechanisms J Neurol Sci 299 55 65 20828765 10.1016/j.jns.2010.08.001
22. D Stauffer N Jan Y He RB Pandey DG Marangoni T Smith-Palmer 1994 Micelle formation, relaxation time, and three-phase coexistence in a microemulsion model J Chem Phys 100 6934 6944 10.1063/1.467009 1:CAS:528:DyaK2cXjtlWrt7o%3D
23. P Stilbs H Walderhaug B Lindman 1983 Micellar fluidity. A deuterium nuclear magnetic resonance spin relaxation study of the anisotropic reorientation of solubilized trans-Decalin-d18 J Phys Chem 87 4762 4769 10.1021/j100246a042 1:CAS:528:DyaL3sXlvVWqu74%3D
24. I Szleifer A Ben-Shaul WM Gelbart 1987 Statistical thermodynamics of molecular organization in mixed micelles and bilayers J Chem Phys 86 7094 7110 10.1063/1.452359 1:CAS:528:DyaL2sXks1GhtLg%3D
25. I Wilhelm AE Farkas P Nagyoszi G Varo Z Balint GA Vegh, et al. 2007 Regulation of cerebral endothelial cell morphology by extracellular calcium Phys Med Biol 52 6261 6274 17921584 10.1088/0031-9155/52/20/012 1:CAS:528: DC%2BD2sXhtlertbvK (Pubitemid 350093193)
26. I Wilhelm C Fazakas IA Krizbai 2011 In vitro models of the blood-brain barrier Acta Neurobiol Exp 71 113 128
27. D Zádori P Klivényi I Plangár J Toldi L Vécsei 2011 Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines J Cell Mol Med 15 701 717 21155972 10.1111/j.1582-4934.2010.01237.x
28. D Zádori G Nyiri A Szonyi I Szatmári F Fülöp J Toldi, et al. 2011 Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease J Neural Transm 118 865 875 21194001 10.1007/s00702-010-0573-6